cyclosporine and Urticaria

cyclosporine has been researched along with Urticaria in 78 studies

Research

Studies (78)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (6.41)	18.2507
2000's	24 (30.77)	29.6817
2010's	41 (52.56)	24.3611
2020's	8 (10.26)	2.80

Authors

Authors	Studies
Chan, TC; Chang, YT; Chen, YJ; Chiu, TM; Cho, YT; Chou, WY; Chu, CY; Hong, CH; Hsiao, PF; Huang, YH; Lan, CC; Lee, CH; Tsai, TF; Tu, WT; Wang, WM; Wu, PY; Yang, CW	1
Alves, F; Calado, R; Gomes, T; Gonçalo, M; Relvas, M	1
Bishnoi, A; Kumaran, MS; Mehta, H; Parsad, D	1
Hsu, JI; Hsu, S	2
Bei, W; Feng, H; Kai, C; Liuqing, C; Qian, J; Ruili, J; Zilu, Q	1
Alvarez, L; Cardona, R; Sánchez, J	1
Expósito-Serrano, V; Garbayo-Salmons, P	1
Ott, H	1
Holm, JG; Ivyanskiy, I; Thomsen, SF	1
Schaefer, P	1
Ferrer, M; Madamba, R	1
Kennedy, KK; Koski, R	2
Weinberger, M	1
Archilla, LR; Curto-Barredo, L; Giménez-Arnau, AM; Pujol, RM; Vives, GR	1
Kaplan, AP	5
Ferreira, B; Gonçalo, M; Ramos, L; Santiago, L	1
Endo, T; Hayama, K; Ito, M; Izaki, S; Kanegae, K; Nishimori, N; Okayama, Y; Sugai, K; Terui, T; Toyoshima, S	1
Hao, P; Huang, Y; Li, Y; Shi, Y; Xiao, X; Xu, M; Zhang, L; Zheng, H; Zheng, Q; Zhou, S	1
Humphreys, F; Kaur, MR; Raghavendran, RR	1
Albanesi, M; Di Stanislao, C; Franconi, G; Guaragna, MA; Paparo Barbaro, S; Stefani, S	1
Garriga-Companys, S; Labrador-Horrillo, M	1
Makris, M; Maurer, M; Zuberbier, T	1
Grattan, C; Marrouche, N	1
Ferreira, MB; Kaplan, AP; Viegas, LP	1
Ardusso, L; Cabrera, H; De Gennaro, M; Fernández Bussy, R; Galimany, J; Galimberti, D; La Forgia, M; Label, M; Máspero, J; Medina, I; Neffen, H; Troielli, P	1
Asero, R	2
Cassano, N; Foti, C; Romita, P; Vena, GA; Ventura, MT; Vestita, M	1
Adamski, H; Aubin, F; Avenel-Audran, M; Bedane, C; Hurabielle, C; Jeanmougin, M; Marguery, MC; Peyron, JL; Poreaux, C; Schmutz, JL; Viguier, M	1
Asero, R; Cugno, M; Marra, AM; Marzano, AV; Pinter, E; Tedeschi, A	1
Chularojanamontri, L; Kulthanan, K; Likitwattananurak, C; Tuchinda, P; Ungaksornpairote, C	1
Deza, G; Giménez-Arnau, AM	1
Bernstein, JA; Greiwe, J	1
Fukunaga, A; Hatakeyama, M; Horikawa, T; Nishigori, C; Ogura, K; Onodera, M; Taguchi, K; Washio, K	1
Berbegal-de Gracia, L; de León-Marrero, F; Hispán, P; Marín-Cabañas, I; Silvestre, JF	1
Costa, C; Gonçalo, M	1
Azzari, C; Barni, S; Bernardini, R; Calogero, C; Cianferoni, A; Di Grande, L; Mori, F; Novembre, E; Pucci, N; Vierucci, A	1
Campanati, A; Ganzetti, G; Giuliodori, K; Marconi, B; Offidani, A; Simonetti, O	1
Bartra, J; Dávila, I; del Cuvillo, A; Ferrer, M; Jáuregui, I; Montoro, J; Mullol, J; Sastre, J; Valero, A	1
Kessel, A; Toubi, E	3
Bajwa, ZH; Najib, U; Ostro, MG; Sheikh, J	1
Tedeschi, A	1
Ohtsuka, T	1
Horimoto, M; Kawasaki, H; Ota, M	1
Boubouka, CD; Charissi, C; Kalogeromitros, D; Katsarou, A; Kouimintzis, D; Stavropoulos, PG	1
Hide, M; Mihara, S; Takahagi, S; Toda, S	1
Hollander, SM; Joo, SS; Wedner, HJ	1
Ardelean, E; Bräutigam, M; Krause, K; Maurer, M; Schoepke, N; Weller, K	1
Altman, K; Chang, C	1
Khan, DA; Trojan, TD	1
Abuchar, A; Dehesa, L; Kerdel, FA; Nuno-Gonzalez, A; Vitiello, M	1
Airaghi, L; Asero, R; Lorini, M; Tedeschi, A	1
Bamberger, E; Kessel, A; Toubi, E	1
Beck, MH; Marsland, AM	1
Baskan, EB; Saricaoglu, H; Tunali, S; Turker, T	1
Joseph, K; Kaplan, AP; Marsland, AM; Soundararajan, S	1
Luger, T; Metze, D; Pullmann, S	1
Wieczorek, D	1
Cassano, N; Colombo, D; Peruzzi, E; Pigatto, P; Vena, GA	1
Lipozencić, J; Ljubojević, S	1
Akcali, C; Kirtak, N; Ozturk, S; Serhat Inaloz, H; Tarakcioglu, M	1
Blant, A; Golan, TD; Kessel, A; Toubi, E	1
Akkoca, MA; Gürer, MA; Ilter, N	1
Ito, S; Saito, T; Sato, H; Soma, J	1
Barlow, RJ; Francis, DM; Grattan, CE; Greaves, MW; Kobza Black, A; Niimi, N; O'Donnell, BF; Seed, PT	1
Cavallo, E; D'Oronzio, L; Dambra, PP; Ferrannini, A; Loria, MP; Nettis, E; Pannofino, A; Tursi, A	1
Greaves, MW; Henz, BM; Juhlin, L; Merk, H; Stingl, G; Zuberbier, T	1
Borja Segade, J; Feo Brito, F; Galindo Bonilla, PA; Gómez Torrijos, E	1
Amon, U; Wolff, HH	1
Ellis, CN; Fradin, MS; Goldfarb, MT; Voorhees, JJ	1

Reviews

23 review(s) available for cyclosporine and Urticaria

Article	Year
Comparing four immunosuppressive agents for chronic spontaneous urticaria-A network meta-analysis. International immunopharmacology, 2023, Volume: 123 Topics: Anti-Allergic Agents; Azathioprine; Chronic Disease; Chronic Urticaria; Cyclosporine; Drug-Related Side Effects and Adverse Reactions; Glycosides; Histamine Antagonists; Histamine H1 Antagonists; Humans; Immunosuppressive Agents; Methotrexate; Network Meta-Analysis; Omalizumab; Randomized Controlled Trials as Topic; Treatment Outcome; Urticaria	2023
[Chronic urticaria in childhood : Rational diagnostics and treatment]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2017, Volume: 68, Issue:7 Topics: Acetates; Angioedema; Child; Child, Preschool; Chronic Disease; Cyclopropanes; Cyclosporine; Diagnosis, Differential; Guideline Adherence; Histamine Antagonists; Humans; Infant; Long-Term Care; Omalizumab; Quinolines; Skin; Sulfides; Urticaria	2017
Use of nonbiologic treatments in antihistamine-refractory chronic urticaria: a review of published evidence. The Journal of dermatological treatment, 2018, Volume: 29, Issue:1 Topics: Anti-Allergic Agents; Chronic Disease; Cyclosporine; Dapsone; Databases, Factual; Drug Resistance; Histamine Antagonists; Humans; Immunoglobulins, Intravenous; Plasmapheresis; Ultraviolet Therapy; Urticaria	2018
Acute and Chronic Urticaria: Evaluation and Treatment. American family physician, 2017, Jun-01, Volume: 95, Issue:11 Topics: Cyclosporine; Dermatologic Agents; Diagnosis, Differential; Histamine H1 Antagonists; Humans; Omalizumab; Urticaria	2017
Biologics in chronic urticaria. Allergologia et immunopathologia, 2017, Volume: 45 Suppl 1 Topics: Animals; Antibodies, Monoclonal; B-Lymphocytes; Biological Therapy; Chronic Disease; Cyclosporine; Humans; Immunoglobulin E; Omalizumab; Rituximab; Tumor Necrosis Factor-alpha; Urticaria	2017
Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria. Allergy and asthma proceedings, 2018, May-01, Volume: 39, Issue:3 Topics: Autoantibodies; Basophils; Chronic Disease; Cyclosporine; Edema; Histamine H1 Antagonists; Humans; Mast Cells; Omalizumab; Receptors, IgE; Skin; Urticaria	2018
Systematic reviews of pharmacological and nonpharmacological treatments for patients with chronic urticaria: An umbrella systematic review. Medicine, 2019, Volume: 98, Issue:20 Topics: Acupuncture Therapy; Anti-Allergic Agents; Chronic Disease; Cyclosporine; Decision Making; Female; Histamine Antagonists; Humans; Immunosuppressive Agents; Leukotriene Antagonists; Male; Medicine, Chinese Traditional; Omalizumab; Quality Improvement; Treatment Outcome; Urticaria	2019
[Chronic spontaneous urticaria]. Medicina clinica, 2014, Mar-20, Volume: 142, Issue:6 Topics: Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Autoimmune Diseases; Chronic Disease; Cyclosporine; Disease Management; Female; Histamine Antagonists; Humans; Immunosuppressive Agents; Male; Omalizumab; Prevalence; Tacrolimus; Urticaria	2014
Pharmacotherapy of chronic spontaneous urticaria. Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:18 Topics: Acetates; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Chronic Disease; Cyclopropanes; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Histamine H1 Antagonists; Histamine Release; Humans; Omalizumab; Practice Guidelines as Topic; Quinolines; Sulfides; Treatment Outcome; Urticaria	2013
Update and insights into treatment options for chronic spontaneous urticaria. Expert review of clinical immunology, 2014, Volume: 10, Issue:3 Topics: Angioedema; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Chronic Disease; Clinical Trials as Topic; Cyclosporine; Drug Resistance; Histamine H1 Antagonists, Non-Sedating; Humans; Immunotherapy; Omalizumab; Pruritus; Skin; Urticaria	2014
Therapy of chronic urticaria: a simple, modern approach. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2014, Volume: 112, Issue:5 Topics: Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Chronic Disease; Cyclosporine; Histamine Antagonists; Humans; Immunosuppressive Agents; Omalizumab; Urticaria	2014
The maddening itch: an approach to chronic urticaria. Journal of investigational allergology & clinical immunology, 2014, Volume: 24, Issue:1 Topics: Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Chronic Disease; Cyclosporine; Histamine Antagonists; Humans; Immunosuppressive Agents; Omalizumab; Pruritus; Urticaria	2014
Current challenges and controversies in the management of chronic spontaneous urticaria. Expert review of clinical immunology, 2015, Volume: 11, Issue:10 Topics: Adrenal Cortex Hormones; Animals; Chronic Disease; Cyclosporine; Humans; Omalizumab; Prevalence; Recurrence; Treatment Failure; Urticaria	2015
Itch in Urticaria Management. Current problems in dermatology, 2016, Volume: 50 Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Chronic Disease; Cyclosporine; Histamine Antagonists; Humans; Immunosuppressive Agents; Leukotriene Antagonists; Omalizumab; Pruritus; Urticaria	2016
Therapy of antihistamine-resistant chronic spontaneous urticaria. Expert review of clinical immunology, 2017, Volume: 13, Issue:4 Topics: Animals; Anti-Inflammatory Agents; Chronic Disease; Cyclosporine; Drug Resistance; Histamine Antagonists; Humans; Omalizumab; Prevalence; Quality of Life; Skin; Urticaria	2017
Urticaria and urticaria related skin condition/disease in children. European annals of allergy and clinical immunology, 2008, Volume: 40, Issue:1 Topics: Autoantibodies; Child; Chronic Disease; Cyclosporine; Epinephrine; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Receptors, IgE; Tacrolimus; Urticaria	2008
Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema. Clinical reviews in allergy & immunology, 2013, Volume: 45, Issue:1 Topics: Angioedema; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Autoantibodies; Autoimmunity; Basophils; Cyclosporine; Histamine Antagonists; Humans; Immunoglobulin E; Intracellular Signaling Peptides and Proteins; Mast Cells; Omalizumab; Protein-Tyrosine Kinases; Receptors, IgE; Signal Transduction; Syk Kinase; Urticaria	2013
Calcineurin inhibitors in chronic urticaria. Current opinion in allergy and clinical immunology, 2012, Volume: 12, Issue:4 Topics: Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Male; Tacrolimus; Time Factors; Urticaria	2012
Biologic agents in the treatment of urticaria. Current allergy and asthma reports, 2012, Volume: 12, Issue:4 Topics: Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Clinical Trials as Topic; Cyclosporine; Humans; Omalizumab; Urticaria	2012
The use of cyclosporine in dermatology. Journal of drugs in dermatology : JDD, 2012, Volume: 11, Issue:8 Topics: Chronic Disease; Cyclosporine; Dermatitis, Atopic; Dermatomyositis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Prurigo; Psoriasis; Pyoderma Gangrenosum; Skin Diseases; Sweet Syndrome; Urticaria	2012
Chronic urticaria: a role for newer immunomodulatory drugs? American journal of clinical dermatology, 2003, Volume: 4, Issue:5 Topics: Adjuvants, Immunologic; Chronic Disease; Cyclosporine; Histamine H1 Antagonists; Humans; Leukotriene Antagonists; Methylprednisolone; Skin Tests; Urticaria	2003
Chronic urticaria: pathogenesis and treatment. The Journal of allergy and clinical immunology, 2004, Volume: 114, Issue:3 Topics: Autoantibodies; Autoimmune Diseases; Chronic Disease; Cyclosporine; Histamine H1 Antagonists; Humans; Immunosuppressive Agents; Steroids; Urticaria	2004
Management of urticaria: a consensus report. The journal of investigative dermatology. Symposium proceedings, 2001, Volume: 6, Issue:2 Topics: Adrenal Cortex Hormones; Cyclosporine; Diet; Histamine H1 Antagonists; Humans; Immunosuppressive Agents; Physical Stimulation; Plasmapheresis; PUVA Therapy; Quality of Life; Urticaria	2001

Trials

9 trial(s) available for cyclosporine and Urticaria

Article	Year
Identification of biomarkers for predicting the response to cyclosporine A therapy in patients with chronic spontaneous urticaria. Allergology international : official journal of the Japanese Society of Allergology, 2019, Volume: 68, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Cyclosporine; Dermatologic Agents; Female; Humans; Immunoglobulin E; Male; Middle Aged; Skin Tests; Treatment Outcome; Urticaria; Young Adult	2019
Chronic urticaria with high IgE levels: first results on oral cyclosporine A treatment. La Clinica terapeutica, 2013, Volume: 164, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Chronic Disease; Cyclosporine; Female; Humans; Immunoglobulin E; Immunosuppressive Agents; Male; Middle Aged; Urticaria; Young Adult	2013
Treatment of autoimmune urticaria with low-dose cyclosporin A: A one-year follow-up. Acta dermato-venereologica, 2011, Volume: 91, Issue:1 Topics: Adolescent; Adult; Aged; Autoantibodies; Autoimmune Diseases; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Urticaria; Young Adult	2011
Comparison of short- and long-term cyclosporine A therapy in chronic idiopathic urticaria. The Journal of dermatological treatment, 2004, Volume: 15, Issue:3 Topics: Adult; Chronic Disease; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Severity of Illness Index; Skin Tests; Treatment Outcome; Urticaria	2004
[Extended cyclosporine-A--treatment for severe chronic urticaria]. Harefuah, 2006, Volume: 145, Issue:6 Topics: Adult; Chronic Disease; Cyclosporine; Dermatologic Agents; Humans; Middle Aged; Prednisone; Treatment Outcome; Urticaria	2006
Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:4 Topics: Adult; Chronic Disease; Cyclosporine; Dermatologic Agents; Double-Blind Method; Female; Humans; Male; Urticaria	2006
Low-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluation. The Journal of dermatology, 2008, Volume: 35, Issue:5 Topics: Adolescent; Adult; Chronic Disease; Cyclosporine; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunosuppressive Agents; Male; Prospective Studies; Treatment Outcome; Urticaria	2008
Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. The British journal of dermatology, 2000, Volume: 143, Issue:2 Topics: Adult; Aged; Algorithms; Basophils; Chronic Disease; Cyclosporine; Dermatologic Agents; Double-Blind Method; Female; Follow-Up Studies; Histamine Release; Humans; Immunosuppressive Agents; Male; Middle Aged; Treatment Outcome; Urticaria	2000
Cyclosporin A in patients affected by chronic idiopathic urticaria: a therapeutic alternative. Immunopharmacology and immunotoxicology, 2001, Volume: 23, Issue:2 Topics: Adult; Anti-Inflammatory Agents; Autoantibodies; B-Lymphocyte Subsets; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Killer Cells, Natural; Male; Middle Aged; Prednisone; T-Lymphocyte Subsets; Urticaria	2001

Other Studies

46 other study(ies) available for cyclosporine and Urticaria

Article	Year
Taiwanese dermatological association consensus for the definition, classification, diagnosis, and management of urticaria: A 2021 update. Journal of the Formosan Medical Association = Taiwan yi zhi, 2022, Volume: 121, Issue:7 Topics: Aged; Child; Chronic Disease; Consensus; Cyclosporine; Female; Humans; Omalizumab; Pregnancy; Urticaria	2022
Short courses of ciclosporin can induce long remissions in chronic spontaneous urticaria. Journal of the European Academy of Dermatology and Venereology : JEADV, 2022, Volume: 36, Issue:8 Topics: Chronic Disease; Chronic Urticaria; Cyclosporine; Humans; Omalizumab; Urticaria	2022
Clinical and laboratory parameters associated with treatment response to third-line therapies in chronic refractory urticaria: A real world study from northern India. Dermatologic therapy, 2022, Volume: 35, Issue:11 Topics: Anti-Allergic Agents; Chronic Disease; Chronic Urticaria; Cyclosporine; Humans; Immunoglobulin E; Omalizumab; Retrospective Studies; Treatment Outcome; Urticaria	2022
Chronic Urticaria. Skinmed, 2022, Volume: 20, Issue:4 Topics: Anti-Allergic Agents; Chronic Disease; Chronic Urticaria; Cyclosporine; Humans; Omalizumab; Urticaria	2022
Chronic Urticaria. Skinmed, 2022, Volume: 20, Issue:5 Topics: Anti-Allergic Agents; Chronic Disease; Chronic Urticaria; Cyclosporine; Humans; Omalizumab; Urticaria	2022
Cyclosporine and omalizumab together: A new option for chronic refractory urticaria. The journal of allergy and clinical immunology. In practice, 2020, Volume: 8, Issue:6 Topics: Anti-Allergic Agents; Chronic Disease; Chronic Urticaria; Cyclosporine; Humans; Omalizumab; Treatment Outcome; Urticaria	2020
Chronic spontaneous urticaria refractory to cyclosporine add-on omalizumab successfully treated with methotrexate add-on. Dermatologic therapy, 2020, Volume: 33, Issue:6 Topics: Anti-Allergic Agents; Chronic Disease; Chronic Urticaria; Cyclosporine; Humans; Methotrexate; Omalizumab; Treatment Outcome; Urticaria	2020
Treatment with omalizumab or cyclosporine for resistant chronic spontaneous urticaria. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2017, Volume: 119, Issue:5 Topics: Anti-Allergic Agents; Chronic Disease; Cyclosporine; Humans; Immunoglobulin E; Immunosuppressive Agents; Omalizumab; Urticaria	2017
Treatment with omalizumab or cyclosporine for resistant chronic spontaneous urticaria? Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2018, Volume: 120, Issue:3 Topics: Anti-Allergic Agents; Cyclosporine; Humans; Omalizumab; Urticaria	2018
Authors' response. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2018, Volume: 120, Issue:3 Topics: Algorithms; Cyclosporine; Humans; Omalizumab; Urticaria	2018
Clinical Features of Chronic Spontaneous Urticaria that Predict Disease Prognosis and Refractoriness to Standard Treatment. Acta dermato-venereologica, 2018, 07-11, Volume: 98, Issue:7 Topics: Adult; Age of Onset; Aged; Chronic Disease; Cyclosporine; Disease Progression; Drug Resistance; Female; Histamine H1 Antagonists; Humans; Immunosuppressive Agents; Male; Middle Aged; Omalizumab; Recurrence; Retrospective Studies; Risk Factors; Time Factors; Treatment Failure; Urticaria	2018
IgE levels are negatively correlated with clinical response to ciclosporin in chronic spontaneous urticaria. The British journal of dermatology, 2019, Volume: 180, Issue:1 Topics: Adult; Biomarkers; Chronic Disease; Cyclosporine; Humans; Immunoglobulin E; Immunosuppressive Agents; Middle Aged; Omalizumab; Retrospective Studies; Treatment Outcome; Urticaria	2019
Successful use of mycophenolate mofetil to treat severe chronic urticaria in a patient intolerant to ciclosporin. Clinical and experimental dermatology, 2014, Volume: 39, Issue:1 Topics: Adult; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Diseases; Mycophenolic Acid; Treatment Outcome; Urticaria	2014
[Argentine guidelines for urticaria and angioedema]. Medicina, 2014, Volume: 74 Suppl 1 Topics: Algorithms; Angioedema; Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Argentina; Autoimmune Diseases; Chronic Disease; Clinical Trials as Topic; Cyclosporine; Diagnosis, Differential; Evidence-Based Medicine; Histamine Antagonists; Humans; Immunoglobulin E; Leukotriene Antagonists; Omalizumab; Quality of Life; Urticaria	2014
Plasma D-dimer levels and clinical response to ciclosporin in severe chronic spontaneous urticaria. The Journal of allergy and clinical immunology, 2015, Volume: 135, Issue:5 Topics: Chronic Disease; Cyclosporine; Fibrin Fibrinogen Degradation Products; Humans; Immunosuppressive Agents; Severity of Illness Index; Treatment Outcome; Urticaria	2015
Management of chronic spontaneous urticaria in the elderly. Drugs & aging, 2015, Volume: 32, Issue:4 Topics: Aged; Chronic Disease; Cyclosporine; Histamine Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Quality of Life; Urticaria	2015
No major effect of cyclosporin A in patients with severe solar urticaria: a french retrospective case series. Acta dermato-venereologica, 2015, Volume: 95, Issue:8 Topics: Adult; Cyclosporine; Dermatitis, Photoallergic; Female; France; Humans; Immunosuppressive Agents; Middle Aged; Retrospective Studies; Sunlight; Treatment Outcome; Urticaria; Young Adult	2015
Omalizumab therapy for treatment of recalcitrant chronic spontaneous urticaria in an Asian population. The Journal of dermatological treatment, 2017, Volume: 28, Issue:2 Topics: Adult; Anti-Allergic Agents; Antibodies, Monoclonal, Humanized; Chronic Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Omalizumab; Prednisolone; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Urticaria	2017
Clinical characteristics in cholinergic urticaria with palpebral angioedema: Report of 15 cases. Journal of dermatological science, 2017, Volume: 85, Issue:2 Topics: Adolescent; Adult; Angioedema; Cyclosporine; Eyelids; Female; Histamine H1 Antagonists; Histamine H2 Antagonists; Histamine Release; Humans; Immunosuppressive Agents; Malassezia; Middle Aged; Olopatadine Hydrochloride; Retrospective Studies; Skin Tests; Urticaria; Young Adult	2017
Management of Chronic Spontaneous Urticaria in Routine Clinical Practice Following the EAACI/GA(2)LEN/EDF/WAO Guidelines. Actas dermo-sifiliograficas, 2017, Volume: 108, Issue:4 Topics: Adrenal Cortex Hormones; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Chronic Disease; Comorbidity; Cross-Sectional Studies; Cyclosporine; Dermatology; Disease Management; Drug Therapy, Combination; Hepatitis, Viral, Human; Histamine H1 Antagonists; Humans; Leukotriene Antagonists; Omalizumab; Practice Guidelines as Topic; Risk Factors; Tertiary Care Centers; Urticaria	2017
[Diagnostic and Therapeutic Approach of Chronic Spontaneous Urticaria: Recommendations in Portugal]. Acta medica portuguesa, 2016, Volume: 29, Issue:11 Topics: Anti-Allergic Agents; Chronic Disease; Cyclosporine; Humans; Omalizumab; Portugal; Quality of Life; Urticaria	2016
A non-responsive chronic autoimmune urticaria in a 12-year-old autistic girl treated with cyclosporin. Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:5 Topics: Autistic Disorder; Autoimmune Diseases; Child; Chronic Disease; Cyclosporine; Female; Humans; Urticaria	2009
What the first 10,000 patients with chronic urticaria have taught me: a personal journey. The Journal of allergy and clinical immunology, 2009, Volume: 123, Issue:3 Topics: Allergens; Autoantibodies; Autoimmunity; Chronic Disease; Cyclosporine; Guidelines as Topic; Histamine Antagonists; Humans; Hydroxyzine; Immunosuppressive Agents; Methotrexate; Urticaria	2009
Chronic urticaria: do urticaria nonexperts implement treatment guidelines? A survey of adherence to published guidelines by nonexperts. The British journal of dermatology, 2009, Volume: 160, Issue:4 Topics: Adult; Chronic Disease; Cross-Sectional Studies; Cyclosporine; Female; Guideline Adherence; Histamine Antagonists; Humans; Immunosuppressive Agents; Leukotriene Antagonists; Male; Middle Aged; Practice Guidelines as Topic; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Urticaria	2009
Low-dose cyclosporine is a good option for severe chronic urticaria. The Journal of allergy and clinical immunology, 2009, Volume: 123, Issue:4 Topics: Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Urticaria	2009
A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2009, Volume: 103, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angioedema; Antibodies, Antinuclear; Autoantibodies; Autoimmunity; Basophil Degranulation Test; Chronic Disease; Cohort Studies; Cyclosporine; Female; Histamine Antagonists; Humans; Immunoglobulin E; Male; Middle Aged; Prednisone; Receptors, IgE; Retrospective Studies; Skin Tests; Thyroid Gland; Urticaria; Young Adult	2009
Paradoxical exacerbation of chronic urticaria by H1-antihistamines and montelukast. European annals of allergy and clinical immunology, 2009, Volume: 41, Issue:6 Topics: Acetates; Adult; Azathioprine; Chronic Disease; Cyclopropanes; Cyclosporine; Histamine H1 Antagonists; Humans; Male; Quinolines; Sulfides; Urticaria	2009
Response to oral cyclosporine therapy and high sensitivity-CRP level in chronic idiopathic urticaria. International journal of dermatology, 2010, Volume: 49, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Basophils; C-Reactive Protein; Chronic Disease; Cyclosporine; Dermatologic Agents; Female; Humans; Male; Middle Aged; Treatment Outcome; Urticaria; Young Adult	2010
Cyclosporine-A in severe chronic urticaria: the option for long-term therapy. Allergy, 2010, Volume: 65, Issue:11 Topics: Chronic Disease; Cyclosporine; Dermatologic Agents; Humans; Urticaria	2010
Ice cream urticaria. The American journal of medicine, 2010, Volume: 123, Issue:12 Topics: Adrenal Cortex Hormones; Adult; Anaphylaxis; Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cold Temperature; Cyclosporine; Histamine Antagonists; Humans; Ice Cream; Immunosuppressive Agents; Male; Omalizumab; Unconsciousness; Urticaria	2010
Six cases of antihistamine-resistant dermographic urticaria treated with oral ciclosporin. Allergology international : official journal of the Japanese Society of Allergology, 2011, Volume: 60, Issue:4 Topics: Adult; Aged; Anti-Allergic Agents; Cyclosporine; Drug Resistance; Female; Histamine H1 Antagonists; Humans; Immunosuppressive Agents; Male; Middle Aged; Treatment Outcome; Urticaria	2011
Factors that predict the success of cyclosporine treatment for chronic urticaria. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2011, Volume: 107, Issue:6 Topics: Administration, Oral; Adult; Chronic Disease; Cohort Studies; Cyclosporine; Dose-Response Relationship, Immunologic; Female; Humans; Immunosuppressive Agents; Male; Retrospective Studies; Urticaria	2011
Selected urticaria patients benefit from a referral to tertiary care centres--results of an expert survey. Journal of the European Academy of Dermatology and Venereology : JEADV, 2013, Volume: 27, Issue:1 Topics: Adult; Aged; Chronic Disease; Cyclosporine; Dermatology; Female; Germany; Health Care Surveys; Histamine Antagonists; Humans; Incidence; Male; Middle Aged; Patient Selection; Prognosis; Referral and Consultation; Risk Assessment; Surveys and Questionnaires; Tertiary Care Centers; Treatment Outcome; Urticaria	2013
Prolonged cyclosporin-A treatment for severe chronic urticaria. Allergy, 2003, Volume: 58, Issue:6 Topics: Chronic Disease; Cyclosporine; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Recurrence; Severity of Illness Index; Urticaria	2003
Cold urticaria responding to systemic ciclosporin. The British journal of dermatology, 2003, Volume: 149, Issue:1 Topics: Aged; Cold Temperature; Cyclosporine; Dermatologic Agents; Female; Humans; Urticaria	2003
Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2005, Volume: 35, Issue:5 Topics: Basophils; Calcineurin Inhibitors; Cells, Cultured; Chronic Disease; Complement C5a; Cyclosporine; Diphenhydramine; Dose-Response Relationship, Immunologic; Histamine H1 Antagonists; Histamine Release; Humans; Hydroxyzine; Immunoglobulin G; Immunosuppressive Agents; Leukocytes; Methotrexate; Recurrence; Tacrolimus; Urticaria	2005
Oral cyclophosphamide in a case of cyclosporin and steroid-resistant chronic urticaria showing autoreactivity on autologous serum skin testing. Clinical and experimental dermatology, 2005, Volume: 30, Issue:5 Topics: Chronic Disease; Cyclophosphamide; Cyclosporine; Drug Resistance; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Middle Aged; Prednisone; Skin Tests; Urticaria	2005
[Papuloerythroderma of Ofuji with urticarial lesions]. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2004, Volume: 2, Issue:6 Topics: Adrenal Cortex Hormones; Aged; Cyclosporine; Dermatitis, Exfoliative; Humans; Immunosuppressive Agents; Male; Paraneoplastic Syndromes; Skin Diseases, Papulosquamous; Urticaria	2004
[Treating chronic urticaria]. MMW Fortschritte der Medizin, 2006, Aug-03, Volume: 148, Issue:31-32 Topics: Adrenal Cortex Hormones; Adult; Child; Chloroquine; Chronic Disease; Cyclosporine; Dapsone; Diagnosis, Differential; Histamine Antagonists; Humans; Pruritus; Urticaria	2006
Cyclosporine in chronic idiopathic urticaria. Acta dermatovenerologica Croatica : ADC, 2007, Volume: 15, Issue:1 Topics: Chronic Disease; Cyclosporine; Dermatologic Agents; Humans; Urticaria	2007
Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy, 1997, Volume: 52, Issue:3 Topics: Adult; Aged; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Skin Tests; Urticaria	1997
Short-term oral cyclosporine for chronic idiopathic urticaria. Journal of the European Academy of Dermatology and Venereology : JEADV, 1999, Volume: 12, Issue:1 Topics: Administration, Oral; Adult; Blood Pressure; Chronic Disease; Creatinine; Cyclosporine; Fatigue; Female; Headache; Humans; Immunosuppressive Agents; Male; Nausea; Treatment Outcome; Urticaria	1999
Nephrotic syndrome associated with hypocomplementaemic urticarial vasculitis syndrome: successful treatment with cyclosporin A. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:7 Topics: Adult; Biopsy; Complement System Proteins; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Glomerulus; Male; Nephrotic Syndrome; Syndrome; Urticaria; Vasculitis, Leukocytoclastic, Cutaneous	1999
Urticaria and cyclosporine. Allergy, 2002, Volume: 57, Issue:7 Topics: Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cyclosporine; Dermatologic Agents; Drug Hypersensitivity; Female; Humans; Middle Aged; Treatment Outcome; Urticaria	2002
Systemic therapy with cyclosporine. Journal of the American Academy of Dermatology, 1992, Volume: 27, Issue:2 Pt 1 Topics: Angioedema; Chronic Disease; Cyclosporine; Humans; Urticaria	1992
Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. Journal of the American Academy of Dermatology, 1991, Volume: 25, Issue:6 Pt 1 Topics: Administration, Oral; Adult; Angioedema; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Humans; Hydroxyzine; Middle Aged; Prednisone; Urticaria	1991